ReviewOncoTargets and therapy2015
The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies.
Akinori SatoPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it